Back to company

MEDCONSULTING INTERNATIONAL ApS: Financial statements 2024

CVR: 28098138

MEDCONSULTING INTERNATIONAL ApS (CVR 28098138) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 167,559 and a net result of DKK 152,391 compared with DKK -6,086 the year before. Equity amounted to DKK 183,291. The solvency ratio was 68%. The company had 1 employee in the financial year.

Gross Profit
167,559 kr.
Profit/Loss
152,391 kr.
Equity
183,291 kr.
Total Assets
269,546 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-168 t.152 t.183 t.1
2023--7 t.-6 t.-169 t.1
2022--8 t.-8 t.-163 t.1
2021--8 t.-8 t.-155 t.1
2020--7 t.-7 t.-147 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MEDCONSULTING INTERNATIONAL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

MEDCONSULTING INTERNATIONAL ApS: The 2023 annual report is outJul 5, 2024

MEDCONSULTING INTERNATIONAL ApS has published its annual report for 2023. Gross profit came to DKK -7,126, and the net result was DKK -6,086.

About MEDCONSULTING INTERNATIONAL ApS

MEDCONSULTING INTERNATIONAL ApS is a Danish company of the type Anpartsselskab based in Rødvig Stevns, founded in 2004. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Carsten Fredsbo. The company is owned by Carsten Fredsbo and RIVERVALE HOLDING ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK -37,817 and a net result of DKK -28,128 compared with DKK 152,391 the year before. Equity amounted to DKK 155,163.